-
Most Popular
Penny Stocks
Penny stocks trade at less than $5 per share. They are highly volatile and incredibly risky investments that can burn new and seasoned investors alike; they often serve as the playground for scam artists and market manipulators. However, while penny stocks can be halved in the blink of an eye, they can also double much more quickly than large-cap stocks. Investors interested in penny stocks should be aware of the risks and do their due diligence before making an investment. Read on to find out how to profit without getting scammed.
7 Space Exploration Stocks That Could Pioneer New Frontiers
Explore space exploration stocks with potential for significant growth as global competition in space technology increases.
3 Stocks to Buy That Could Turn Your Beer Money Into Champagne Showers
These three high-potential stocks could potentially turn a small investment into significant returns. Consider throwing in some beer money.
3 Stocks Under $15 That Could Make You a Millionaire
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying.
Other Stock Types you might be interested in
Recent Penny Stocks Articles
Why Is ContraFect (CFRX) Stock Down 80% Today?
A Phase 3 trial of ContraFect's treatment for antibiotic-resistant infections has been stopped, and CFRX stock is plunging.
What Is Going on With Qurate Retail (QRTEB) Stock Today?
Today's big head scratcher is Quarate Retail, a company that's seen its QRTEB stock surge more than 60% on little news.
Best Stocks for 2022: POSaBIT Is a Top Penny Stock in a Bumpy Year
Investing in any penny stock comes with risks, but POSAF stock is a unique opportunity that could very well be 2022's best penny stock.
Why Is Digital World (DWAC) Stock Roaring Higher Today?
Digital World Acquisition Corp. (DWAC) stock is jumping after Elon Musk disclosed that he would not seek to buy Twitter.
Aprea Therapeutics (APRE) Stock Soars as Wedbush Sets $3 Price Target
Wedbush analyst Robert Driscoll just gave a huge upside target for APRE stock. Here’s why this is significant for the biotech sector.
Clovis Oncology (CLVS) Stock Gains as Shareholders Reject Reverse Stock Split
Clovis' (CLVS) shareholders decided to reject a proposal for a reverse split of CLVS stock. Clovis' shares appear to be rising on the news.
Why Is Endo International (ENDP) Stock Up Today?
After a week of roller-coaster price action, ENDP stock is on the upswing even after Endo International posts disappointing clinical results.
Why Is Endo International (ENDP) Stock Up 90% Today?
Endo International has been surging all day but it isn't just Plan B that has kept it rising. Here's why ENDP stock is a name to watch.
Evofem Biosciences (EVFM) Stock Remains in Spotlight With Contraception Access Deal
Evofem Biosciences has already announced a strategic partnership. Here's why this new deal is great news for EVFM stock.
Travel Stocks TOUR, TCOM Rise as China Loosens Quarantine Requirements
As China eases up on its strict “zero Covid” policy, some travel stocks are heading north with same-day double-digit gains.
3 Penny Stocks That Have Huge Catalysts Ahead
While you don’t want to play with money you can’t afford to lose, these penny stocks might bring home the goods for the bold.
Why Is Asia Broadband (AABB) Stock Up 35% Today?
Investors in Asia Broadband and AABB stock finally have a catalyst to jump on, as this stock surges 30% in today's session.
Why Are Clean Energy Stocks JKS, GEVO, CLNE, DQ Up Today?
Here's why clean energy stocks are also seeing significant buying pressure following the G7 summit meetings today.
Ebang (EBON) Stock Rallies 20% After Nasdaq Delisting Warning
In an odd move, shares of Chinese blockchain company Ebang are rallying today after it said EBON stock could be delisted in the U.S.
Is Borqs Technologies (BRQS) Stock Really Up 1,000% Today?
BRQS stock was up more than 1,000% in pre-market trading, but the move occurred because it underwent a 1-for-16 reverse split.
Why Is Epizyme (EPZM) Stock Up 75% Today?
Epizyme stock is up nearly 65% today on news that the biotechnology company is going to be acquired by French pharmaceutical concern Ipsen.
